Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicplas InternationalSGX:569 Days Payable is 66.54 as of Jan. 2026, which is 49% above its 10-year median of 44.54. The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Vicplas International ranks worse than 51.57% on this metric.
The historical rank and industry rank for Vicplas International's Days Payable or its related term are showing as below:
SGX:569'
s Days Payable Range Over the Past 10 Years
Min: 34.74 Med: 44.54 Max: 81.5
Current: 67.22
During the past 13 years, Vicplas International's highest Days Payable was 81.50. The lowest was 34.74. And the median was 44.54.
SGX:569's Days Payable is ranked worse than 51.57% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs SGX:569: 67.22
Vicplas International Days Payable Historical Data
* Premium members only.
The historical data trend for Vicplas International's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Vicplas International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Days Payable distribution charts can be found below:
* The bar in red indicates where Vicplas International's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vicplas International's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicplas International (SGX:569) has a Days Payable of 66.54 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vicplas International and its competitors. This is 49% above median its historical median of 44.54. Over the past decade, Vicplas International's Days Payable has ranged from 34.74 to 81.50. According to the industry distribution chart, Vicplas International ranks #410 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 51.6%.
Is Vicplas International's Days Payable too high?
Vicplas International's current Days Payable of 66.54 is 49% above median its 10-year median of 44.54. Over the past 10 years, this metric has ranged from a low of 34.74 to a high of 81.50. The Medical Devices & Instruments industry median Days Payable is 67.87. Vicplas International's value of 66.54 is 2% below this industry median. Based on the distribution chart, Vicplas International ranks #410 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Vicplas International's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vicplas International ranks #410 out of 795 companies for Days Payable. This places Vicplas International in the lower half of its industry. The industry median Days Payable is 67.87. Vicplas International's value of 66.54 is 2% below this benchmark. Historically, Vicplas International's own Days Payable has ranged from 34.74 to 81.50 over the past decade. While the company's 10-year median is 44.54 vs. the industry median of 67.87, Vicplas International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vicplas International's current Days Payable of 66.54 is 2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vicplas International and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicplas International's current Days Payable is 66.54, which is 49% above median its own 10-year median of 44.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current Days Payable is 66.54, which is 49% above median its 10-year median of 44.54 and 2% below the Medical Devices & Instruments industry median of 67.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vicplas International (SGX:569), the current Days Payable is 66.54 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:569 has been successfully added to your 
